Achromobacter xylosoxidans was isolated from six patients. The organism causes opportunistic infections in patients who are compromised. A. xylosoxidans is a catalase-and oxidase-positive, motile, gram-negative rod that oxidizes xylose and glucose. The organism exists in a water environment and may be confused with Pseudomonas species. Unlike pseudomonas, achromobacter has peritrichous flagella. The clinical and laboratory characteristics of A. xylosoxidans are presented.
Achromobacter xylosoxidans, an aerobic, nonfermentative, gram-negative rod, is rarely isolated from clinical material. The organism was initially characterized by Holmes et al. (3) and further studied and named by Yabuuchi and Ohyama (12) . A. xylosoxidans can be confused with other nonfermentative, gram-negative rods, especially pseudomonas species, in clinical specimens so that its role as a significant pathogen may be underestimated.
The purpose of this report is to describe our experience with A. xylosoxidans isolated from different body sites of six patients on seven occasions during the last three years. CASE REPORTS Case 1. A 69-year-old black male was admitted in July 1976 for generalized exfoliative dermatitis and bilateral otitis externa. Past history revealed treatment of the exfoliative dermatitis for 12 (Table 3) were resistant to the currently used aminoglycosides but were sensitive to polymyxin B and trimeth-[a, a characteristic oprim/sulfamethoxazole. All of our strains were ism from Pseudom-sensitive to carbenicillin but were resistant to other semisynthetic penicillins. Some strains tibiotic susceptibil-were sensitive to chloramphenicol, tetracycline, determined by the and colistin. A similar pattern with some varia- VOL. 11, 1980 on November 2, 2017 by guest http://jcm.asm.org/ tion has been reported in the literature (3, 4, 8, 10, 12, 13) .
Clinically, A. xylosoxidans has been isolated from many types of specimens, most frequently from the urine, blood, respiratory tract, spinal fluid, and ears (Table 4) . Unfortunately, sufficient clinical information is missing from most descriptions. Thus, it is difficult to assess the clinical significance of its isolation. The fact that A. xylosoxidans is frequently isolated in combination with other organisms makes it even more difficult to determine its pathogenic role (8) . However, there are a few well-described cases in which its pathogenic role is clearly demonstrated (10) .
A. xylosoxidans can be considered an opportunistic pathogen. Dworzack et al. (2) described a patient with a community-acquired bacteremic pneumonia due to A. xylosoxidans who was found to have a deficiency of immunoglobulin M. Of the four opportunistic infections due to A. xylosoxidans described by Holmes et al. (3) , one patient received extensive chemotherapy for breast carcinoma, another had metastatic adenocarcinoma in the liver, a third patient was on chronic steroid inhalation therapy, and a fourth patient had a chronic orbit infection after numerous surgical procedures. Shigeta et al. (10) described six patients with cerebral ventriculitis due to A. xylosoxidans that occurred after neurosurgical operations. Also, the use of prolonged or broad-spectrum antibiotic therapy has been suggested as a possible cause of infection with this organism (3, 10) . The common denominator in all patients appears to be a breakdown in host defense mechanisms that allows this opportunistic pathogen to cause infection. and from the wash basins on their surgical wards (10) . It is possible that the patient with peritonitis described above may have acquired his infection from contaminated peritoneal dialysate fluid containers.
In conclusion, A. xylosoxidans causes opportunistic infections in patients with underlying illnesses. The organism probably exists in a water environment and can be confused with Pseudomonas species. The organism is usually sensitive to carbenicillin, commonly sensitive to chloramphenicol, tetracycline, and trimethoprim/sulfamethoxazole, and resistant to other penicillins and currently used aminoglycosides.
